MARKET

ATNM

ATNM

Actinium Pharmac
AMEX
0.9700
-0.0800
-7.62%
After Hours: 0.9700 0 0.00% 16:10 07/08 EDT
OPEN
1.050
PREV CLOSE
1.050
HIGH
1.050
LOW
0.9601
VOLUME
72.61K
TURNOVER
--
52 WEEK HIGH
1.890
52 WEEK LOW
0.9365
MARKET CAP
30.43M
P/E (TTM)
-1.2896
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ATNM last week (0629-0703)?
Weekly Report · 3d ago
Weekly Report: what happened at ATNM last week (0622-0626)?
Weekly Report · 06/29 10:19
Weekly Report: what happened at ATNM last week (0615-0619)?
Weekly Report · 06/22 10:28
Actinium Submits NYSE Compliance Plan to Restore Listing
TipRanks · 06/18 23:46
Weekly Report: what happened at ATNM last week (0608-0612)?
Weekly Report · 06/15 10:29
Weekly Report: what happened at ATNM last week (0601-0605)?
Weekly Report · 06/08 10:24
Actinium presented preclinical data on ATNM-400 in NSCLC at SNMMI 2026
TipRanks · 06/03 13:39
Actinium's ATNM-400 Reports Preclinical Activity And Combination Synergy Across KRAS- And EGFR-Mutant NSCLC, Supporting Mutation-Agnostic Potential
Benzinga · 06/03 12:11
More
About ATNM
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company pioneering the development of targeted radiotherapies to address significant unmet medical needs in oncology. It operates a pipeline of both early and later stage development programs with two novel solid tumor product candidates, ATNM-400 and Actimab-A, with pan-tumor potential; Actimab-A, which is also being developed as a therapeutic backbone for acute myeloid leukemia and myelodysplastic syndrome in partnership with the National Cancer Institute (NCI), and two targeted conditioning agents, Iomab-B for bone marrow transplant and Iomab-ACT for cell & gene therapies. Its solid tumor asset, ATNM-400, targets a novel antigen distinct from PSMA, with demonstrated preclinical activity across metastatic castration-resistant prostate cancer (mCRPC), non-small cell lung cancer (NSCLC), and breast cancer. Its hematology franchise includes Actimab-A, Iomab-B and Iomab-ACT, which are CD45-targeting conditioning agents.

Webull offers Actinium Pharmaceuticals Inc stock information, including AMEX: ATNM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATNM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATNM stock methods without spending real money on the virtual paper trading platform.